The federal appeals court on Thursday granted temporary approval to the National Institutes of Health for funding the human embryonic stem cell researches, but apprehensions are still pertaining regarding the future in the field.
Last month, the United States Court of Appeals for the District of Columbia obstructed the ban that scrapped the funding for the stem cell researches. Both the parties were asked to submit more details by September
20. Till the case gets settled down, financing can be applied to the contentious research.
Francis Collins, NIH Director said, "We are pleased with the court's interim ruling, which will allow this important, life-saving research to continue while we present further arguments to the court in the weeks to come".
Now, the question that is hovering around is if the law called Dickey-Wicker Amendment abandons the Government from pooling any funds to the stem cell research from tax payers' money. As per the Department of Health and Human Services, the law restricts funding into researches that destroy embryos, while NIH is supporting financially those studies that examine embryos for finding therapies for diabetes, Parkinson's disease or spinal cord injuries.
But, as there is no long-term commitment for the financing of the researches, scientists are in a fix to move ahead with their plans. Similar problem was confronted by Dr. Anthony Blau, co-director of the University of Washington Institute for Stem Cell and Regenerative Medicine in Seattle, who was planning to hire a lab researcher to assist studying cancer with embryonic stem cells, which he had to postpone.